Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New treatment guidelines for HIV-infected adults, adolescents now posted

May 6, 1999

BioChem Pharma identifies novel lead NNRTI: BCH-1

May 5, 1999

HIV-1 TAT variants and their use in anti-AIDS therapy disclosed by Transgene

May 5, 1999

Kissei prepares to file for approval of amprenavir in Japan

May 5, 1999

Boston Biomedica and UNC expand natural products agreement

May 5, 1999

Novel benzylhydroxylamine with potent and selective anti-HIV activity undergoes further testing

May 4, 1999

Anti-CCR5 MAb acts as potent HIV inhibitor

May 4, 1999

Phase I pharmacokinetic, safety and efficacy results reported for KNI-272

April 30, 1999

DuPont presents new series of HIV reverse transcriptase inhibitors

April 30, 1999

Vitravene recommended for European approval as CMV retinitis therapy

April 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...